Mayo Clinic
Rochester, Minnesota, 55905, United States
NCT Number: NCT02862522
Uric acid is a risk factor for coronary artery disease (CED) in postmenopausal women but the association with inflammation and coronary microvascular endothelial dysfunction is not well-defined. The aim of this study was to determine the relationship of serum uric acid, inflammatory markers and CED.
Looking for future studies?
Notify Me50 year and older
Female
Observational
Rochester, Minnesota, 55905, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The standardized questionnaire was used to assess occurrence of major adverse cardiovascular events including stroke, re-hospitalization, myocardial infarction or death. Responses were verified by medical record review conducted by an investigator blinded to the results of the standardized questionnaire.
Time frame: Baseline
Mayo Clinic
Other
Clinical Follow-up of Patients With Assessment of Endothelial Dysfunction/Coronary Spasm
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04776629
Arterial Occlusive Diseases, Arteriosclerosis
Scottsdale, Arizona, United States
View Trial DetailsNCT04907253
Arterial Occlusive Diseases, Arteriosclerosis
Montreal, Quebec, Canada
View Trial DetailsNCT06508437
Arterial Occlusive Diseases, Arteriosclerosis
Tours, France
View Trial DetailsNCT04382443
Acute Coronary Syndrome, Arterial Occlusive Diseases
Ciudad de Buenos Aires, Buenos Aires, Argentina
View Trial Details